文献速递呼吸危重症与机械通气呼吸道感染

高频胸壁振荡在急性呼吸衰竭伴支气管高分泌患者中的随机对照试验

High-Frequency Chest Wall Oscillation in Acute Respiratory Failure With Bronchial Hypersecretion: A Randomized Controlled Trial.
PubMed 文献 · Chest · 2026-10-14

主要终点治疗性支气管镜需求在调整后无统计学差异(调整OR 0.336,95%CI 0.111-1.021;P=0.055)。住院时间和RICU时间缩短,HFNC持续时间缩短且调整后仍显著,插管率和死亡率无差异。

要点

  • HFCWO未显著降低调整后治疗性支气管镜需求(P=0.055)
  • HFCWO组住院和RICU时间缩短,HFNC持续时间缩短且调整后显著
  • 无患者需插管,死亡率无差异,结果需多中心验证

核心结论

  • 在探索性试验中,HFCWO调整后未显著减少治疗性支气管镜需求。
  • 住院时间和HFNC持续时间缩短为假设生成性结果,需确证。

研究设计与样本

  • 单中心随机对照试验,在呼吸重症监护病房(RICU)进行。
  • 主要终点为治疗性支气管镜,次要终点包括住院时间、RICU时间、无创呼吸支持持续时间、插管和死亡率。

主要发现

  • 治疗性支气管镜需求:HFCWO组6例(13.6%)vs 对照组14例(31.8%),未调整P=0.042;调整后OR 0.336(95%CI 0.111-1.021),P=0.055。
  • 住院时间:12(10-15.5)天 vs 16.5(13-21)天,调整后减少4.5天。
  • RICU时间:8(7-10.5)天 vs 12(9-17)天,调整后减少3.6天。
  • HFNC持续时间:6(4-8)天 vs 9.5(6-11.5)天,调整后仍显著;NIV持续时间减少调整后不显著(调整P=0.166)。
  • 无患者需要插管,死亡率无差异。

关键数值与推荐

  • 纳入标准:急性呼吸衰竭需HFNC和/或NIV,支气管高分泌,峰值咳嗽呼气流速<270 L/min。
  • 主要终点调整模型校正年龄、性别和主要住院原因。

临床怎么用

  • 对于急性呼吸衰竭需无创呼吸支持伴支气管高分泌和咳嗽无效的患者,可考虑加用HFCWO以缩短住院和HFNC时间。
  • HFCWO对治疗性支气管镜需求的获益尚不确定,需个体化评估。

局限性

  • 次要终点未校正多重检验,结果为探索性。
  • 主要终点调整后未达统计学显著性,需多中心大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Airway secretion retention is common in patients with acute respiratory failure (ARF), particularly in those requiring noninvasive respiratory support (NIRS). High-frequency chest wall oscillation (HFCWO) may improve airway clearance but critical care evidence remains limited. RESEARCH QUESTION: Does adding HFCWO to standard care improve clinical outcomes in patients with bronchial hypersecretion and ARF requiring NIRS? STUDY DESIGN AND METHODS: We conducted a single-center randomized controlled trial in a RICU. Patients with ARF requiring NIRS, including high-flow nasal cannula (HFNC) and/or noninvasive ventilation (NIV), bronchial hypersecretion, and ineffective cough (peak cough expiratory flow <270 L/min) were randomized 1:1 to HFCWO plus standard care or standard care alone. The primary endpoint was therapeutic bronchoscopy. Secondary endpoints included hospital length of stay (LOS), RICU-LOS, NIRS duration, endotracheal intubation and mortality. Outcomes were analyzed using unadjusted and adjusted models accounting for age, sex, and main cause of hospitalization. RESULTS: Eighty-eight patients were enrolled (44 HFCWO, 44 control), with comparable baseline characteristics. Bronchoscopy was required in 6 patients (13.6%) versus 14 (31.8%) (unadjusted p=0.042); after adjustment the association did not retain statistical significance (adjusted OR 0.336, 95% CI 0.111-1.021; p=0.055). Secondary outcomes, analyzed without correction for multiple testing, are exploratory. Hospital stay (12 [10-15.5] vs 16.5 [13-21] days) and RICU stay (8 [7-10.5] vs 12 [9-17] days) were shorter, with adjusted reductions of 4.5 and 3.6 days. HFNC duration was shorter (6 [4-8] vs 9.5 [6-11.5] days) and remained significant after adjustment, whereas the reduction in NIV duration did not (adjusted p=0.166). No patient required intubation and mortality did not differ. INTERPRETATION: In this exploratory trial, HFCWO did not significantly reduce the need for therapeutic bronchoscopy after adjustment. Associated reductions in LOS and HFNC duration are hypothesis-generating and require confirmation in adequately powered multicenter trials. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: NCT05751707; Tuscany Ethics Committee (Protocol: 21987-10/17/2022).

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ielo S, Golfi N, Guidelli L, et al. High-Frequency Chest Wall Oscillation in Acute Respiratory Failure With Bronchial Hypersecretion: A Randomized Controlled Trial. Chest. 2026. PMID: 42874912. doi:10.1016/j.chest.2026.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。